Ying Zhao1, Ailian Liu1, Tao Lin1, Qingwei Song1, Yu Yao2,3, Han Wen2,3, Xin Li4, Yan Guo4, and Tingfan Wu4
1The First Affiliated Hospital of Dalian Medical University, Dalian, China, 2Chengdu Institute of Computer Application, Chinese Academy of Sciences, Chengdu, China, 3University of Chinese Academy of Sciences, Beijing, China, 4GE Healthcare (China), ShangHai, China
1The First Affiliated Hospital of Dalian Medical University, Dalian, China, 2Chengdu Institute of Computer Application, Chinese Academy of Sciences, Chengdu, China, 3University of Chinese Academy of Sciences, Beijing, China, 4GE Healthcare (China), ShangHai, China
This study showed
that contrast-enhanced MRI radiomics was capable to predict therapeutic response
in hepatocellular carcinoma treated with transcatheter arterial
chemoembolization, which will provide some guidance for treatment decisions.
Table
1. Discriminative performance of
different predictive models in the training and validation cohorts
Figure 1. ROC curves for the radiomics model,
clinical-radiological model, and combined model in the training cohort (a) and
validation cohort (b).